drugset / Trial / NCT06699420
Qishenyiqi Dripping Pill for Coronary Microvascular Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To investigate the efficacy and safety of Qishenyiqi in patients with microvascular angina pectoris. Long-term follow-up of 1 year will be performed to evaluate the effect of Qishenyiqi on coronary flow reserve and adverse cardiovascular events in patients with coronary microvascular disease.
Timeline
- Start
- 2023-11-08
- Primary completion
- 2025-12-31
- Completion
- 2026-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Qishen Yiqi dripping pills | Traditional medicine (herbal / TCM) | 1 unknown | — |